Phase 1 – Discovery & Data Foundations
Start with workflow mapping of your personal health journey: appointment scheduling, blood draw, results, supplement adjustment, history review. Note where files, screenshots, or apps come into play and answer:
- Which biomarkers are missing in structured form?
- Which devices or apps already provide you data (wearable, lab portal, PDF)?
- Where are you still working manually?
- Which insights do you want to see regularly (trend, delta, reminder)?
Once you have these answers, you can decide which steps to automate.
Phase 2 – Implementing Quick Wins
- Self-Service Uploads: Upload results directly to Lab2go; the system reads biomarkers, references, and supplements.
- Auto Reference Values: Let reference ranges be set by age, gender, or target range so deviations stand out immediately.
- Reminder Engine: Schedule blood tests, supplements, or lifestyle checks as reminders so your history has no gaps.
Phase 3 – Scaling & Governance
- Role-based Access: Share only the values someone really needs – e.g., vitamin D for your family doctor.
- Personal KPI Boards: Create simple dashboards for biomarkers, supplements, and history so everyone knows what happened last.
- Feedback Loops: Block 15 minutes monthly to review insights and formulate new questions for your data.
Results
After six weeks of structure, users report:
- 35% less time spent sorting new results.
- Twice as many detected trends because biomarkers, supplements, and insights are displayed together.
- More confidence in conversations with doctors because history and notes are at hand.
The key: start small, measure consistently, and align every automation so you better understand your own health outcomes.
Article FAQ
- How do I start with LabOps without my own team?
- Map your journey from blood test to insight, prioritize bottlenecks, and only then automate reminders and uploads.
- Which KPIs should I track?
- Time per result, detected trends, and number of established routines show whether your LabOps structure is working.
Discussion
Community comments coming soon. Until then, we welcome feedback and questions via email.
E-Mail anzeigen